David M Mott's Net Worth
Estimate Recalculated Jun 12, 2025 08:30PM EST
Who is David M Mott
David M Mott has an estimated net worth of $45.6 Million. This is based on reported shares across multiple companies, which include PhaseBio Pharmaceuticals Inc, Ra Pharmaceuticals, Inc., Cloudflare, Inc., RHYTHM PHARMACEUTICALS, INC., TESARO, Inc., Dermira, Inc., Cascadian Therapeutics, Inc., Workday, Inc., Care.com Inc, Millennial Media Inc., AEROHIVE NETWORKS, INC, Mersana Therapeutics, Inc., MULESOFT, INC, Elastic N.V., NOVAVAX INC, Oyster Point Pharma, Inc., AVEO PHARMACEUTICALS INC, Sprout Social, Inc., APPIAN CORP, Clovis Oncology, Inc., Mirum Pharmaceuticals, Inc., Adaptimmune Therapeutics PLC, BOX INC, Nightstar Therapeutics plc, Loxo Oncology, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., GENOCEA BIOSCIENCES, INC., Millendo Therapeutics, Inc., ARDELYX, INC., Galera Therapeutics, Inc., Trevi Therapeutics, Inc., GLYCOMIMETICS INC, Tracon Pharmaceuticals, Inc., Mirna Therapeutics, Inc., Epizyme, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Cerecor Inc., Roka BioScience, Inc., Regulus Therapeutics Inc., ARCA biopharma, Inc., IMARA Inc., Marker Therapeutics, Inc., Omthera Pharmaceuticals, Inc., Strongbridge Biopharma plc, CVENT INC, Achaogen Inc, Casper Sleep Inc., INTERLEUKIN GENETICS INC, and MEDIMMUNE INC /DE.
SEC CIK
David M Mott's CIK is 0001219871
Past Insider Trading and Trends
2022 was David M Mott's most active year for acquiring shares with 23 total transactions. David M Mott's most active month to acquire stocks was the month of May. 2007 was David M Mott's most active year for disposing of shares, totalling 13 transactions. David M Mott's most active month to dispose stocks was the month of May. 2020 saw David M Mott paying a total of $6,096,962.40 for 1,383,466 shares, this is the most they've acquired in one year. In 2007 David M Mott cashed out on 5,840,580 shares for a total of $34,762,590.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
